Collaborations

Ablitech’s sophisticated and flexible delivery technologies provide the company with unmatched potential to develop solutions for delivering antisense to a wide variety of degenerative disease tissue.

                 



Ablitech, Inc. is actively seeking corporate partnerships, strategic alliances and small pharmaceutical grant partners to fully develop the vast potential of its proprietary technologies. Please contact us to discuss potential collaborations.